Abstract P4-01-14: Two-week change in optical tomography predicts residual cancer burden score in women treated with neoadjuvant chemotherapy
EA Lim(Columbia University Irving Medical Center), DL Hershman(Columbia University Irving Medical Center), JE Gunther(Columbia University Irving Medical Center), Bret Taback(Columbia College), Kevin Kalinsky(Emory University), Matthew J. Maurer(Mayo Clinic in Arizona), Susan Refice(Columbia College), Marlon De Wayne Brown(Columbia University Irving Medical Center), Preya Ananthakrishnan(Columbia University Irving Medical Center), Molly Flexman(Philips (United States)), Hanina Hibshoosh, Hyung‐Kwan Kim(Seoul National University), Sheldon Feldman(Presbyterian Hospital), Andreas H. Hielscher(New York University), Kathy Crew(Columbia University Irving Medical Center)
Cited by 0
Related Papers
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846
A molecular single-cell lung atlas of lethal COVID-19
|Nature|2021|735